Your browser doesn't support javascript.
loading
Population pharmacokinetic/pharmacodynamic modeling of delayed effect of escitalopram-induced QT prolongation.
Kim, Yun; Kim, Anhye; Chung, Jae-Yong.
Affiliation
  • Kim Y; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea.
  • Kim A; Department of Clinical Pharmacology and Therapeutics, CHA Bundang Medical Center, CHA University, Seongnam, Republic of Korea.
  • Chung JY; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Bundang Hospital, Seongnam, Republic of Korea. Electronic address: jychung@snubh.org.
J Affect Disord ; 285: 120-126, 2021 04 15.
Article in En | MEDLINE | ID: mdl-33647579

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Long QT Syndrome / Citalopram Type of study: Clinical_trials Limits: Humans Language: En Journal: J Affect Disord Year: 2021 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Long QT Syndrome / Citalopram Type of study: Clinical_trials Limits: Humans Language: En Journal: J Affect Disord Year: 2021 Document type: Article